211 related articles for article (PubMed ID: 17100599)
1. Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context.
Johnson DG; Degregori J
Curr Mol Med; 2006 Nov; 6(7):731-8. PubMed ID: 17100599
[TBL] [Abstract][Full Text] [Related]
2. E2F1 in gliomas: a paradigm of oncogene addiction.
Alonso MM; Alemany R; Fueyo J; Gomez-Manzano C
Cancer Lett; 2008 May; 263(2):157-63. PubMed ID: 18334281
[TBL] [Abstract][Full Text] [Related]
3. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis.
DeGregori J; Johnson DG
Curr Mol Med; 2006 Nov; 6(7):739-48. PubMed ID: 17100600
[TBL] [Abstract][Full Text] [Related]
4. Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs.
Gupta T; Sáenz Robles MT; Pipas JM
J Virol; 2015 May; 89(9):5124-33. PubMed ID: 25717106
[TBL] [Abstract][Full Text] [Related]
5. The Rb-E2F transcriptional regulatory pathway in tumor angiogenesis and metastasis.
Schaal C; Pillai S; Chellappan SP
Adv Cancer Res; 2014; 121():147-182. PubMed ID: 24889531
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
7. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
Wang S; Nath N; Adlam M; Chellappan S
Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
[TBL] [Abstract][Full Text] [Related]
8. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
9. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
10. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of E2F family member oncogenic activity.
Chen C; Wells AD
PLoS One; 2007 Sep; 2(9):e912. PubMed ID: 17878947
[TBL] [Abstract][Full Text] [Related]
13. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
14. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
15. The cellular effects of E2F overexpression.
Adams PD; Kaelin WG
Curr Top Microbiol Immunol; 1996; 208():79-93. PubMed ID: 8575214
[TBL] [Abstract][Full Text] [Related]
16. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
17. Role of E2F transcription factor in oral cancer: Recent insight and advancements.
Kassab A; Gupta I; Moustafa AA
Semin Cancer Biol; 2023 Jul; 92():28-41. PubMed ID: 36924812
[TBL] [Abstract][Full Text] [Related]
18. Role of E2F in cell cycle control and cancer.
Johnson DG; Schneider-Broussard R
Front Biosci; 1998 Apr; 3():d447-8. PubMed ID: 9556498
[TBL] [Abstract][Full Text] [Related]
19. pRb and E2f-1 in mouse development and tumorigenesis.
Macleod K
Curr Opin Genet Dev; 1999 Feb; 9(1):31-9. PubMed ID: 10072353
[TBL] [Abstract][Full Text] [Related]
20. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
